We conducted a double-blind, placebo-controlled trial to evaluate the effects of an oral food supplement (OFS) on long COVID patients, particularly focusing on chronic inflammation and fatigue. The supplement included components like rosehip, propolis, royal jelly, and zinc, with vitamin C being a key ingredient.
Through our two-month study, which involved giving participants either the OFS or a placebo, we made some interesting observations. Notably, patients who took the OFS experienced a significant reduction in inflammatory markers, which are often linked to chronic fatigue syndrome. This included improvements in the neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios.
We also noted a substantial increase in vitamin D levels among those taking the supplement, which correlated with enhanced quality of life and decreased fatigue as measured by the fatigue severity scale. Our findings suggest that the combination of ingredients in the OFS, particularly its vitamin D content, can help alleviate some symptoms associated with long COVID, especially chronic fatigue.
However, since the supplement included multiple active ingredients, isolating the specific impact of vitamin D on chronic fatigue syndrome is challenging. Still, the overall results indicate positive changes for patients dealing with the lingering effects of COVID.